A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness

Simple item page
dc.contributor.authorBardien, Soraya
dc.contributor.authorHuman, Hannique
dc.contributor.authorHarris, Tashneem
dc.contributor.authorHefke, Gwynneth
dc.contributor.authorVeikondis, Rene
dc.contributor.authorSchaaf, H. Simon
dc.contributor.authorVan der Merwe, Lize
dc.contributor.authorGreinwald, John H.
dc.contributor.authorFagan, Johan
dc.contributor.authorDe Jong, Greetje
dc.date.accessioned2010-12-14T08:24:34Z
dc.date.available2010-12-14T08:24:34Z
dc.date.issued2009-01
dc.date.updated2010-11-02T13:11:30Z
dc.description.abstractBackground: South Africa has one of the highest incidences of multidrug-resistant tuberculosis (MDR-TB) in the world. Concomitantly, aminoglycosides are commonly used in this country as a treatment against MDR-TB. To date, at least five mutations are known to confer susceptibility to aminoglycoside-induced hearing loss. The aim of the present study was to develop a rapid screening method to determine whether these mutations are present in the South African population. Methods: A multiplex method using the SNaPshot technique was used to screen for five mutations in the MT-RNR1 gene: A1555G, C1494T, T1095C, 961delT+C(n) and A827G. A total of 204 South African control samples, comprising 98 Mixed ancestry and 106 Black individuals were screened for the presence of the five mutations. Results: A robust, cost-effective method was developed that detected the presence of all five sequence variants simultaneously. In this pilot study, the A1555G mutation was identified at a frequency of 0.9% in the Black control samples. The 961delT+C(n) variant was present in 6.6% of the Black controls and 2% of the Mixed ancestry controls. The T1095C, C1494T and A827G variants were not identified in any of the study participants. Conclusion: The frequency of 0.9% for the A1555G mutation in the Black population in South Africa is of concern given the high incidence of MDR-TB in this particular ethnic group. Future larger studies are warranted to determine the true frequencies of the aminoglycoside deafness mutations in the general South African population. The high frequencies of the 961delT+C(n) variant observed in the controls suggest that this change is a common non-pathogenic polymorphism. This genetic method facilitates the identification of individuals at high risk of developing hearing loss prior to the start of aminoglycoside therapy. This is important in a low-resource country like South Africa where, despite their adverse side-effects, aminoglycosides will continue to be used routinely and are accompanied with very limited or no audiological monitoring.en_ZA
dc.description.versionPeer Reviewed
dc.identifier.citationBardien, S, Human, H, Harris, T, Hefke, G, Veikondis, R, Schaaf, HS, Van der Merwe, L, Greinwald, JH, Fagan, J & De Jong, G 2009. 'A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness', BMC Medical Genetics, 10(1):2.en_ZA
dc.identifier.issn1471-2350
dc.identifier.otherhttp://dx.doi.org/10.1186/1471-2350-10-2
dc.identifier.urihttp://hdl.handle.net/10019.1/5084
dc.language.isoen_ZAen_ZA
dc.language.rfc3066en
dc.publisherBioMed Centralen_ZA
dc.rights.holderBardien et al.; licensee BioMed Central Ltd.en_ZA
dc.subjectMultidrug-resistant tuberculosis (MDR-TB)en_ZA
dc.subjectAminoglycosides mutationsen_ZA
dc.subjectAminoglycoside-induced hearing lossen_ZA
dc.subjectSNaPshot techniqueen_ZA
dc.titleA rapid method for detection of five known mutations associated with aminoglycoside-induced deafnessen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
bardien_rapid_2009.pdf
Size:
249.06 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Molecular Biology and Human Genetics)
Research Articles (Paediatrics and Child Health)